Lytus Technologies Holdings PTV. LTD. (LYT)
Company Description
Lytus Technologies Holdings is a growing platform services company primarily providing content streaming/telecasting services with over 8 million active users located all across India.
Our scope of business also covers telemedicine services with local assistance through local Health Centers. Through our platform, our customers are well connected via customer premises equipment (“CPE”) devices/set top boxes (“STBs) and have access to multi-dimensional services.
We have been focused on adopting and implementing technologies that can change the landscape of being a conventional streaming services provider. We intend to benefit from India’s e-commerce boom and the recent tele-medicine regulation through the acquisition of Global Health Sciences, Inc. (“GHSI”).
Our healthcare work will focus on providing telemedicine solutions for the unmet medical needs of a large part of the Indian population. Our unique addition to conventional telemedicine is in the form of local health centers staffed by trained nurses, both male and female, to assist the doctor to thoroughly examine the patient and administer treatment such injections as per the advice of the doctor on the video consultation.
Country | India |
Founded | 2020 |
IPO Date | Jun 15, 2022 |
Industry | Software-Application |
Sector | Technology |
Employees | 38 |
CEO | Dharmesh Pandya |
Contact Details
Address:
601 Everest Grande, A Wing, Mahakali Caves Road Andheri (East), Mumbai 400 093 India | |
Phone | 91 28 4494 2810 |
Stock Details
Ticker Symbol | LYT |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | US Dollars |
IPO Price | $4.75 |
CIK Code | 1816319 |
SIC Code | 7374 |
Key Executives
Name | Position |
---|---|
Dharmesh Pandya | Chief Executive Officer and Director |
Shreyas Shah | Chief Financial Officer ? Global and Director |
Jagjit Singh Kohli | India Chief Executive Officer - IPTV and Director |
Rajeev Kheror | Global C.E.O - OTT and Studios |
James Tuchi | USA Chief Executive Officer of Telemedicine |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jun 23, 2022 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] |
Jun 16, 2022 | 424B4 | Prospectus [Rule 424(b)(4)] |
Jun 15, 2022 | EFFECT | Notice of Effectiveness |
Jun 14, 2022 | CERT | Certification by an exchange approving securities for listing |
Jun 13, 2022 | 8-A12B | Registration of securities [Section 12(b)] |
Jun 8, 2022 | POS AM | Post-Effective amendments for registration statement |
Jun 1, 2022 | POS AM | Post-Effective amendments for registration statement |
May 4, 2022 | POS AM | Post-Effective amendments for registration statement |
Apr 6, 2022 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses |
Apr 1, 2022 | EFFECT | Notice of Effectiveness |